Октреотид, 111 In

Октреотид, 111 In Uses, Dosage, Side Effects, Food Interaction and all others data.

Октреотид, 111 In has been used in trials studying the diagnosis of Cushing's syndrome.

Table Of contents

• Октреотид, 111 In
• Uses
• Dosage
• Side Effect
• Precautions
• Interactions
• Uses during Pregnancy
• Uses during Breastfeeding
• Accute Overdose
• Food Interaction
• Half Life
• Volume of Distribution
• Clearance
• Interaction With other Medicine
• Contradiction
• Storage

Trade Name	Октреотид, 111 In
Generic	Pentetreotide
Pentetreotide Other Names	Pentetreotida, Pentetreotide
Type
Formula	C63H87N13O19S2
Weight	Average: 1394.58 Monoisotopic: 1393.568259981
Groups	Approved, Investigational
Therapeutic Class
Manufacturer
Available Country	Russia
Last Updated:	September 19, 2023 at 7:00 am

Uses

Октреотид, 111 In is a somatostatin receptor inhibitor, available in a kit with Indium-111, used as a contrast agent in the visualization of somatostatin receptor-positive neuroendocrine tumours.

Октреотид, 111 In is also used to associated treatment for these conditions: Carcinoid Tumors, Gastroenteropancreatic neuroendocrine tumors (GEP-NETs)

Innovators Monograph

You find simplified version here Октреотид, 111 In